Catalyst Wire Dossier Catalyst Wire Dossier

EBV-specific T cell therapy

EBV-specific T cells
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EBV-specific T cell therapy, covering 2016-12-02 to 2016-12-02. Get the full timeline:

Most recent: Clinical Trial Update: A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application [Phase 1, Phase 2]

See pricing